Ozempic Shortage by State Tracker October 2026
Pharmaceutical availability gaps remain a burden on people across the country. This page provides up-to-date tracking on what’s available and what to do.
Stock Status
Based on the latest data, availability for GLP-1 medications varies significantly by:
- Drug and dose: Initial titration doses are frequently easier to find than target doses
- Geographic location: Distribution networks prioritize major metro regions while smaller markets get less
- Where you fill: Mail-order options occasionally access products not in chain supply
Dose-Specific Tracking
Beginning Doses
Low-dose strengths are typically in better supply because:
- A smaller population remains on starting strength permanently
- Manufacturers allocate more capacity to these strengths to maintain new patient access
Higher Dosing
Target dosing are more constrained because:
- The majority of users accumulate at higher doses and continue long-term
- Output lags behind as more patients titrate up
Action Plan
Right Now
- Phone before visiting — don’t visit any location without confirming that they have it
- Try multiple locations — try several locations not just chains
- Ask about waiting lists — many pharmacies can alert you when stock arrives
Extended Supply Issues
- Reach out to your provider about dose adjustments — a doctor can suggest dose splitting
- Consider compounded options — should your prescription be formally listed, compounded alternatives are legally available
- Contact the drug maker — the manufacturers provide services to locate medication
Where to Track
Use these resources to keep current:
- FDA.gov shortage page — the authoritative source
- Manufacturer websites — production news published by the manufacturers
- Your pharmacy app — some show medication status
- Support groups — community members share real-time where they found it
We refresh this tracker as conditions change.